Healthcare_medical .

Login now to join in the fun!

latest updates

  • Mass Spectrometry Market Size and Growth: A Quantitative Analysis https://www.marketsandmarkets.com/Market-Reports/mass-spectrometry-market-437.html The global mass spectrometry market is projected to reach USD 7.8 billion by 2028 from USD 5.4 billion in 2023, growing at a CAGR of 7.5% during the forecast period. Increasing spending on pharmaceutical R&D primarily drives the growth of this market in mass spectrometry, government regulations on drug safety, growing focus on the quality of food products further supports the market growth. However, recession impact impedes the market growth. The mass spectrometry business is very competitive, with both established companies and newcomers competing for the same market share. As of 2022, the key players operating in the global mass spectrometry market are SCIEX AB (US), Thermo Fisher Scientific (US), Agilent Technologies (US), Waters Corporation(US), PerkinElmer Inc. (US), Shimadzu Corporation (Japan) and Bruker Corporation (US) among others.
  • Healthcare_medical
  • Competitive Landscape in Medical Aesthetics: Key Players and Market Share https://www.marketsandmarkets.com/Market-Reports/medical-aesthetics-market-885.html The global medical aesthetics market is projected to reach USD 25.9 billion by 2028 from USD 15.4 billion in 2023, at a CAGR of 11.0% from 2023 to 2028. The rising prevalence of targeted diseases and increasing technological advancements fuel the market growth. The medical aesthetics market is moderately competitive, with established companies and upcoming competitors for the same market share. As of 2022, the key players operating in the global medical aesthetics market are Abbvie Inc (US), Galderma (Switzerland), Johnson & Johnson (US), Bausch Health Companies Inc. (Canada), and Cutera. (US) among others.
  • Healthcare_medical
  • Enteral Feeding Devices Market Landscape: Competitive Analysis and Growth Strategies https://www.marketsandmarkets.com/Market-Reports/enteral-feeding-device-market-183623035.html The global enteral feeding devices market is projected to reach USD 5.2 billion by 2027 from USD 3.7 billion in 2022, growing at a CAGR of 6.9% during the forecast period. Enteral feeding devices are extensively used for delivering medication and nutrition therapy during the healthcare treatments. Growth in this market is largely driven by the shift from parenteral to enteral nutrition. Additionally, the growing use of enteral feeding in the home care treatments, high incidence of preterm births and genetic disorders among neonatal and pediatrics, and the growing prevalence of chronic diseases are also driving the market growth. However, insufficient reimbursements for enteral nutrition and the complications associated with the use of enteral feeding devices are some of the major challenges that are hampering the market growth.
  • Healthcare_medical
  • Patient Handling Equipment Industry Report: Market Share, Growth, and Forecast https://www.marketsandmarkets.com/Market-Reports/patient-handling-equipment-market-186358368.html The global patient handling equipment market is projected to reach USD 14.0 billion by 2027 from USD 10.4 billion in 2022, at a CAGR of 6.2% during the forecast period. Growth in this market is largely driven by the increasing number of geriatric and obese populations, growing risk of accidents to caregivers while manually handling patients, rising number of patient admissions in hospitals, and the implementation of regulations and guidelines to ensure healthcare worker safety during the manual lifting. However, improper training provided to healthcare providers for the efficient operation of patient handling equipment is a major challenge that is hampering the market growth.
  • Healthcare_medical
  • Global Tissue Engineering Market Analysis: Current Trends and Future Outlook https://www.marketsandmarkets.com/Market-Reports/tissue-engineering-market-34135173.html The tissue engineering market is projected to reach USD 8.9 billion by 2028 from an estimated USD 4.4 billion in 2023, at a CAGR of 15.3% during the forecast period. The major factors driving the growth of this tissue engineering market include increasing demand for regenerative medicines, growing investments for the developments of the biopharmaceutical field, and increasing incidence and prevalence of chronic and degenerative diseases. The global tissue engineering market is competitive with top players such as AbbVie Inc. (US), Baxter (US), Integra Lifesciences (US), Organogenesis Inc. (US), and Medtronic (Ireland) . The market players have adopted various strategies such as acquisitions, new product launches, collaborations, agreements, and geographical expansions to strengthen their position in the global tissue engineering market.
  • Healthcare_medical
  • Comprehensive Study on Temperature Management Systems: Market Size, Share, and Trends https://www.marketsandmarkets.com/Market-Reports/temperature-management-market-141546773.html The global temperature management systems market is projected to reach USD 3.9 Billion by 2028 from USD 3.0 Billion in 2023, at a CAGR of 4.9% during the forecast period. Growth in this market is mainly driven by the increasing prevalence of chronic and infectious diseases, the rising number of surgical procedures, and the increasing number of hypothermia cases. The temperature management systems market is consolidated and is dominated by various players. The major players operating in this market are 3M Company (US), Asahi-kasei Corporation (Japan), Becton, Dickinson and Company (US), GE Healthcare (US) and Dragerwerk AG & Co. KGAA (Germany). These include product launches, contracts, partnerships, mergers and acquisitions, and new product development activities further to expand their presence in the temperature management systems Market.
  • Healthcare_medical
  • Beyond Skin Deep: Exploring Transdermal Patches Market Dynamics https://www.marketsandmarkets.com/Market-Reports/transdermal-patches-market-190809043.html The global transdermal patches market is projected to reach 8.0 USD billion by 2029 from USD 6.2 billion in 2023, at a CAGR of 4.5% from 2023 to 2029. The increasing prevalence of chronic diseases, growing adoption of analgesic patches, technological advancements in a transdermal patches, and switching from conventional injections to transdermal patches are all factors driving the growth of the global transdermal patches market. However, throughout the projected period, factors including the drug failure and recalls of transdermal drug delivery systems and the rising cost of healthcare facilities will likely restrict market growth to some extent. The prominent players in the global transdermal patches market are Johnson & Johnson (U.S.), Viatris Inc. (U.S.), Hisamatsu Pharmaceuticals Co. Ltd. (Japan), Novartis AG (Switzerland), USB S.A. (Belgium), Boehringer Ingelheim International GmbH (Germany), Endo International plc. (Ireland), Luye Pharma Group (China), AbbVie Inc. (U.S.), Nitto Denko Corporation (Japan), Cipla Inc. (India), Teva Pharmaceutical Industries Ltd. (Israel), Agile Therapeutics (U.S.), Bayer AG (Germany), Amneal Pharmaceuticals LLC. (U.S.), Hikma Pharmaceuticals PLC (U.K.), Alvogen Group Inc. (U.S.), Sparsha Pharma International Pvt Ltd (India), Iontopatch (U.S.), Medherant Limited (U.K.), AdhexPharma (France), Evernow (U.S.), LEAD CHEMICAL Co., Ltd. (Japan), Purdue Pharma L.P (U.S.) and Mundipharma International (U.K.).
  • Healthcare_medical
  • Veterinary APIs in Livestock Farming: Market Developments and Opportunities https://www.marketsandmarkets.com/Market-Reports/veterinary-api-market-91801752.html The Global Veterinary API Market is projected to reach USD 11.9 billion by 2028 from USD 8.5 billion in 2023, at a CAGR of 6.9% the forecast period. There are several factors which drive the Veterinary API Market like rising incidence of transboundary & zoonotic diseases, increasing animal population and pet ownership, and increasing disease control & disease prevention measures. The veterinary API industry is anticipated to develop because of the rising demand for veterinary medicines and other animal health products. The market for Veterinary API Market is dominated by companies like Phibro Animal Health Corporation (US), Fabbrica Italiana Sintetici S.p.A. (Italy), Sequent Scientific Ltd. (India), Excel Industries Ltd. (India), NGL Fine-Chem Ltd. (India), Insud Pharma (Spain), Menadiona Sl (Spain), Rochem International Inc. (US), and Shaanxi Hanjiang Pharmaceutical Group Co. Ltd. (China)
  • Healthcare_medical
  • Impact of Technology Integration in Point of Care Molecular Diagnostics: Market Size and Forecast https://www.marketsandmarkets.com/Market-Reports/point-of-care-molecular-diagnostic-market-143524127.html The global point-of-care molecular diagnostics market size is projected to reach USD 3.4 billion by 2028 from USD 2.0 billion in 2023, at a CAGR of 10.6% during the forecast period. Growth in the point-of-care molecular diagnostics industry is mainly driven by factors such as the increasing incidence of infectious diseases and cancer, increasing R&D funding to reduce time required for testing, growing awareness about early diagnosis of testing and technological advancements. The major players in this market are Abbott Laboratories (US), F. Hoffmann-La Roche Ltd. (Switzerland), bioMérieux SA (France), Danaher Corporation (US), QIAGEN N.V. (Netherlands), QuidelOrtho Corporation (US), Co-Diagnostics, Inc. (US), Biocartis NV (Belgium), Meridian Bioscience, Inc. (US), Thermo Fisher Scientific, Inc. (US), Lucira Health, Inc. (US), Cue Health (US), OpGen, Inc. (US), Binx Health, Inc. (US), Molbio Diagnostics Pct. Ltd. (India), Genomadix (Canada), Visby Medical, Inc. (US), QuikPath PTE Ltd. (Singapore), MD-Bio (US), QuantuMDx Group Ltd. (UK), Aidian Oy (Finland), GeneSTAT Molecular Diagnostics, LLC. (US), Labsystems Diagnostics Oy (Finland), Akonni Biosystems (US) and Curetis N.V. (Germany).
  • Healthcare_medical
  • Impact of Technological Integration in Enteral Feeding: Market Size and Forecast https://www.marketsandmarkets.com/Market-Reports/enteral-feeding-device-market-183623035.html The global enteral feeding devices market is projected to reach USD 5.2 billion by 2027 from USD 3.7 billion in 2022, growing at a CAGR of 6.9% during the forecast period. Enteral feeding devices are extensively used for delivering medication and nutrition therapy during the healthcare treatments. Growth in this market is largely driven by the shift from parenteral to enteral nutrition. Additionally, the growing use of enteral feeding in the home care treatments, high incidence of preterm births and genetic disorders among neonatal and pediatrics, and the growing prevalence of chronic diseases are also driving the market growth. However, insufficient reimbursements for enteral nutrition and the complications associated with the use of enteral feeding devices are some of the major challenges that are hampering the market growth.
  • Healthcare_medical
  • Endoscopy in Gastrointestinal Procedures: Market Developments and Opportunities https://www.marketsandmarkets.com/Market-Reports/endoscopy-devices-market-689.html Endoscopy Equipment Market is projected to reach USD 40.6 billion by 2027 from USD 28.9 billion in 2022, at a CAGR of 7.0%. Endoscopy Equipment Market by Product (Endoscope (Flexible, Rigid, Capsule, Robot-assisted, Disposable), Visualization Systems (Video Converters, Recorders, Processors), Other endoscopic, Accessories), Application, End User - Global Forecast to 2027 The growth in this market is driven by Surging requirement for endoscopy to diagnose and treat target diseases, increasing investments, funds, and grants by governments and other organizations worldwide to improve healthcare infrastructure and research areas of endoscopy and Increasing preference for minimally invasive surgeries. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=689 Endoscopy Equipment Industry Key Market Players: Prominent players in the endoscopy equipment market include Olympus Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Stryker Corporation (US), Boston Scientific Corporation (US), JOHNSON & JOHNSON (US), Fujifilm Holdings Corporation (Japan), Medtronic, Inc. (Ireland), HOYA Corporation (Japan), Nipro Corporation (Japan), Intuitive Surgical, Inc. (US) and Smith & Nephew plc (UK). Based on product, the endoscopes segment is expected to account for the largest share of the endoscopy equipment market The endoscopes segment accounted for the largest share of the global endoscopy equipment market in the forecast period. The large share of this segment can be attributed to the rising preference of patients and doctors for minimally invasive procedures, higher adoption rate of these equipment by end users, and ongoing advancements in endoscopy technologies. On the basis of application, gastrointestinal endoscopy segment is expected to account for the largest share of the endoscopy equipment market Based on application, the gastrointestinal endoscopy segment accounted for the largest share of the endoscopy equipment market in the forecast period. This segment is also expected to witness the highest CAGR of 7.8% during the forecast period. The highest growth rate of this segment can be subjected to the increasing geriatric population in Asia Pacific region, rising incidence of colorectal cancer (CRC) in younger adults in US and Canada, which leads to growing screening using GI endoscopy of the target population for CRC screening. Based on end user, hospitals segment holds the highest market share in the endoscopy equipment market Based on end user, the hospitals segment is likely to dominate the endoscopy equipment market during the forecast period owing to the increasing government and private funding in the healthcare sector, rising adoption of endoscopy equipment in hospitals, as well as the greater availability of skilled healthcare professionals and technologically advanced facilities. Based on Region, North America to dominate the endoscopy equipment market during the forecast period The endoscopy equipment market in North America dominated the endoscopy equipment market in the forecast period. The largest share of North America in the global market is attributed to increased prominence of IBD, high investments by hospitals to purchase new endoscopic equipment for screening of cancers, polyps and other indications, as well as the implementation of a new funding model by Canadian hospitals. Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=689 Endoscopy Equipment Market Dynamics: Drivers: 1. Surging requirement for endoscopy to diagnose and treat target diseases 2. Increasing investments, funds, and grants by governments and other organizations worldwide 3. Growing focus of hospitals to invest in technologically advanced endoscopy instruments and expand endoscopy units 4. Ongoing advancements in endoscopic technologies to ensure patient safety and achieve more accurate treatments 5. Rising requirement of endoscopy procedures due to increased incidence of chronic diseases 6. Increasing preference for minimally invasive surgeries 7. Adoption of single-use endoscopy instruments to prevent infectious diseases and offer increased safety 8. Rising focus of medical specialists to shift from manual to automated endoscopy reprocessing Restraints: 1. Unfavorable healthcare reforms in US 2. High overhead costs of endoscopy procedures with limited reimbursement in developing countries 3. High risk of viral infections during endoscopic procedures Opportunities: 1. Booming healthcare sector in developing economies Challenges: 1. Product recalls witnessed by major market players 2. Infections caused by some endoscopy products offered by giant companies 3. Shortage of trained physicians and endoscopists Recent Developments: • In February 2021. Olympus Corporation (Japan) launched SIF-H190 single balloon enteroscopy solution, a endoscopy system to reach deep into the small intestine. • In June 2021, Johnson & Johnson (US) Launched the ENSEAL X1 Curved Jaw Tissue Sealer, an advanced bipolar energy device that increases procedural efficiency and provides stronger sealing and better access to more tissues. • In May 2019, FUJIFILM Corporation built a new smart manufacturing facility in the site of FUJIFILM Techno Products Co., Ltd., which is one of Fujifilm’s production bases for endoscopy products. The new manufacturing facility is fully operational from September 2019. This new manufacturing facility will utilize AI and IoT technologies to achieve high production efficiency. Browse Adjacent Market: Medical Devices Market Research Reports & Consulting Research Insight: https://www.marketsandmarkets.com/ResearchInsight/endoscopy-devices-market.asp Content Source: https://www.marketsandmarkets.com/PressReleases/endoscopy.asp
  • Healthcare_medical
  • Impact of Robotics and AI in Lab Automation: Market Size and Forecast https://www.marketsandmarkets.com/Market-Reports/lab-automation-market-1158.html The global lab automation market is projected to reach USD 7.1 billion by 2028 from USD 5.1 billion in 2022, growing at a CAGR of 5.8% during the forecast period. Rising technological advancements primarily drive the growth of this market in lab automation, rise in demand for miniaturize process equipment further supports the market growth. However, higher initial investment impedes the market growth. However, the slow adoption of lab automation by some laboratories and the long waiting period for workflow implementation are expected to restrain the market growth. The lab automation business is very competitive, with both established companies and newcomers competing for the same market share. As of 2022, the key players operating in the global lab automation market are Thermo Fisher Scientific (US), Tecan Group (Switzerland), Danaher Corporation (US), Agilent Technologies (US), F. Hoffmann-La Roche (Switzerland), PerkinElmer (US), Eppendorf (Germany), Becton, Dickinson and Company (US), Waters Corporation (US), Siemens Healthineers (Germany), Abbott Laboratories (US), bioMérieux (France), Endress+Hauser Group (Switzerland), Hamilton Company (US), and Hudson Robotics (US) among others.
  • Healthcare_medical
  • 3D Cell Culture for Drug Discovery and Development: Market Outlook https://www.marketsandmarkets.com/Market-Reports/3d-cell-culture-market-191072847.html The 3D cell culture market is estimated to reach USD 2.5 billion by 2028 from USD 1.3 billion in 2023, at a CAGR of 14.6% during the forecast period. The growth of this market is mainly driven increasing adoption of 3D cell culture over 2D cell culture and rising demand for personalized medicine across the globe. The prominent players operating in the 3D cell culture market are include Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Corning Incorporated (US), Lonza Group AG (Switzerland), and Avantor Inc. (US).
  • Healthcare_medical
  • Mass Spectrometry in Food Safety: Market Trends and Regulatory Landscape https://www.marketsandmarkets.com/Market-Reports/mass-spectrometry-market-437.html The global mass spectrometry market is projected to reach USD 7.8 billion by 2028 from USD 5.4 billion in 2023, growing at a CAGR of 7.5% during the forecast period. Increasing spending on pharmaceutical R&D primarily drives the growth of this market in mass spectrometry, government regulations on drug safety, growing focus on the quality of food products further supports the market growth. However, recession impact impedes the market growth. The mass spectrometry business is very competitive, with both established companies and newcomers competing for the same market share. As of 2022, the key players operating in the global mass spectrometry market are SCIEX AB (US), Thermo Fisher Scientific (US), Agilent Technologies (US), Waters Corporation(US), PerkinElmer Inc. (US), Shimadzu Corporation (Japan) and Bruker Corporation (US) among others.
  • Healthcare_medical
  • The Growing Promise of Antibody Drug Conjugates: Market Trends and Outlook https://www.marketsandmarkets.com/Market-Reports/antibody-drug-conjugates-market-122857391.html The antibody drug conjugates market is projected to reach USD 19.8 Billion by 2028 from USD 9.7 Billion in 2023, at a CAGR of 15.2% during the forecast period. Growth in the antibody drug conjugates market can be attributed to factors such as the collaborations and partnerships among market players for the development of new ADCs, and the rising number of government approvals for antibody drug conjugates. The global antibody drug conjugates market is highly competitive. The prominent players operating in this market include F. Hoffmann-La Roche Ltd (Switzerland), Daiichi Sankyo Company, Limited (Japan), Seagen Inc. (US), Gilead Sciences, Inc. (US), Takeda Pharmaceutical Company Limited (Japan), Pfizer Inc. (US), Astellas Pharma Inc (Japan), AstraZeneca (UK), ADC Therapeutics SA (Switzerland), ImmunoGen, Inc. (US), and Zydus Group (India), among others.

0 following